GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phaarmasia Ltd (BOM:523620) » Definitions » Investments And Advances

Phaarmasia (BOM:523620) Investments And Advances : ₹0.0 Mil (As of Dec. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Phaarmasia Investments And Advances?

Phaarmasia's Investments And Advances for the quarter that ended in Dec. 2024 was ₹0.0 Mil.


Phaarmasia Investments And Advances Historical Data

The historical data trend for Phaarmasia's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phaarmasia Investments And Advances Chart

Phaarmasia Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Phaarmasia Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Phaarmasia Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Phaarmasia Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 16, Phase III, IDA, Jeedimetla, Hyderabad, TG, IND, 500055
Phaarmasia Ltd is a pharmaceutical company based in India. It is engaged in the manufacturing of Oral Contraceptive Pills and Combipack with Iron tablets. It offers hormone and herbal products. The company operates in one operating segment namely, Manufacturing and sale of OCPs, and derives prime revenue from India.

Phaarmasia Headlines

No Headlines